BioCryst Pharmaceuticals, Inc. (BCRX) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal…
Source: Yahoo Finance
Sector & Industry
BioCryst Pharmaceuticals, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
BioCryst Pharmaceuticals, Inc. at a Glance
| Company | BioCryst Pharmaceuticals, Inc. |
| Ticker | BCRX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $9.96 |
| Market cap | $2.55B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.40 |
| 52-week high | $11.22 |
| 52-week low | $6.00 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.56 |
| Return on equity (ROE) | — |
| Debt-to-equity | — |
| Average volume | 4.24M |
| Shares outstanding | 255.54M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 435 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is BioCryst Pharmaceuticals, Inc.'s current P/E ratio?
- BioCryst Pharmaceuticals, Inc. (BCRX) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is BioCryst Pharmaceuticals, Inc.'s market capitalisation?
- BioCryst Pharmaceuticals, Inc.'s market cap is $2.55B based on our latest snapshot. See how it ranks by market cap →
- What is BCRX's 52-week range?
- Over the past 52 weeks, BCRX has traded between $6.00 and $11.22. What does the 52-week range mean? →
- How volatile is BioCryst Pharmaceuticals, Inc. compared to the market?
- BioCryst Pharmaceuticals, Inc. has a beta of 0.56, meaning it has historically moved less than the broader market. What does beta measure? →
- Does BioCryst Pharmaceuticals, Inc. pay a dividend?
- BioCryst Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is BCRX listed on?
- BCRX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is BioCryst Pharmaceuticals, Inc. in?
- BioCryst Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →